| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.32B | 54.38B | 55.05B | 68.26B | 62.28B | 44.34B |
| Gross Profit | 17.93B | 17.12B | 18.00B | 24.48B | 19.34B | 11.65B |
| EBITDA | 4.73B | 5.90B | 8.48B | 14.01B | 9.78B | 4.08B |
| Net Income | 2.01B | 978.00M | 2.67B | 7.47B | 4.13B | 215.00M |
Balance Sheet | ||||||
| Total Assets | 120.52B | 120.67B | 119.19B | 114.35B | 107.08B | 100.95B |
| Cash, Cash Equivalents and Short-Term Investments | 24.17B | 24.43B | 19.77B | 18.85B | 18.00B | 15.49B |
| Total Debt | 31.96B | 34.90B | 32.71B | 22.12B | 23.86B | 29.22B |
| Total Liabilities | 44.20B | 45.03B | 43.02B | 42.69B | 43.11B | 41.52B |
| Stockholders Equity | 76.32B | 75.63B | 76.16B | 71.66B | 63.97B | 59.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.27B | -7.50B | 4.06B | 8.29B | 2.55B |
| Operating Cash Flow | 0.00 | 6.45B | -2.49B | 6.40B | 10.27B | 5.66B |
| Investing Cash Flow | 0.00 | -3.44B | -5.30B | -2.70B | -2.10B | -3.01B |
| Financing Cash Flow | 0.00 | 912.00M | 7.57B | -3.35B | -6.44B | -412.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥25.23B | 12.05 | ― | 2.74% | 8.60% | 9.08% | |
74 Outperform | €95.02B | 21.51 | 2.64% | 2.54% | -4.11% | 46.76% | |
70 Outperform | ¥49.24B | 23.91 | ― | 3.36% | 8.75% | 177.16% | |
70 Outperform | ¥20.47B | 16.48 | ― | 3.92% | 0.97% | -10.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥5.26B | -26.48 | ― | 2.11% | -7.53% | -136.56% | |
52 Neutral | ¥15.91B | -8.81 | ― | 6.27% | -11.60% | -255.37% |